.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Express Scripts
McKesson
Baxter
Fish and Richardson
Boehringer Ingelheim
Johnson and Johnson
Citi
Julphar
Dow

Generated: June 22, 2017

DrugPatentWatch Database Preview

VELOSEF Drug Profile

« Back to Dashboard

What is the patent landscape for Velosef, and when can generic versions of Velosef launch?

Velosef is a drug marketed by Bristol Myers Squibb, Apothecon, and Ersana. and is included in five NDAs.

The generic ingredient in VELOSEF is cephradine. There are ten drug master file entries for this compound. Additional details are available on the cephradine profile page.

Summary for Tradename: VELOSEF

Patents:0
Applicants:3
NDAs:5
Bulk Api Vendors: see list34
Patent Applications: see list3,286
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VELOSEF at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
VELOSEF
cephradine
TABLET;ORAL050530-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Apothecon
VELOSEF
cephradine
INJECTABLE;INJECTION061976-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Apothecon
VELOSEF
cephradine
INJECTABLE;INJECTION061976-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ersana
VELOSEF '500'
cephradine
CAPSULE;ORAL050548-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Apothecon
VELOSEF
cephradine
INJECTABLE;INJECTION061976-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Covington
Colorcon
Novartis
Moodys
US Army
McKesson
Federal Trade Commission
Baxter
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot